Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme. (Q45997277)
Jump to navigation
Jump to search
scientific article published on 4 November 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme. |
scientific article published on 4 November 2016 |
Statements
1 reference
Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme. (English)
1 reference
Julia Y Ljubimova
1 reference
Szu-Ting Chou
1 reference
Rameshwar Patil
1 reference
Anna Galstyan
1 reference
Pallavi R Gangalum
1 reference
Webster K Cavenee
1 reference
Vladimir A Ljubimov
1 reference
Alexandra Chesnokova
1 reference
Andrei A Kramerov
1 reference
Hui Ding
1 reference
Vida Falahatian
1 reference
Irving Fox
1 reference
Keith L Black
1 reference
Eggehard Holler
1 reference
Alexander V Ljubimov
1 reference
4 November 2016
1 reference
244
1 reference
Pt A
1 reference
14-23
1 reference
Identifiers
1 reference